Sign in or create an account to add this stock to your watchlist.
About Balchem (NASDAQ:BCPC)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include creamer and chocolate systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, ice cream bases and variegates, cereals, grain based snacks, and cereal based ingredients. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. Its Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The company's Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. It also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company's Industrial Products segment provides choline chloride derivatives for hydraulic fracturing of shale natural gas wells; and methylamines, which are building blocks for the manufacture of choline products, as well as used in industrial applications. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was founded in 1967 and is headquartered in New Hampton, New York.
Industry, Sector and Symbol
Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
SymbolNASDAQ:BCPC
CUSIP05766520
Phone845-326-5600
Debt
Debt-to-Equity Ratio0.28
Current Ratio2.16
Quick Ratio1.48
Price-To-Earnings
Trailing P/E Ratio35.62
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$594.79 million
Price / Sales5.23
Cash Flow$3.9539 per share
Price / Cash24.50
Book Value$19.93 per share
Price / Book4.86
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$90.07 million
Net Margins15.18%
Return on Equity14.50%
Return on Assets9.03%
Miscellaneous
Employees1,165
Outstanding Shares32,110,000
Balchem (NASDAQ:BCPC) Frequently Asked Questions
What is Balchem's stock symbol?
Balchem trades on the NASDAQ under the ticker symbol "BCPC."
How often does Balchem pay dividends? What is the dividend yield for Balchem?
Balchem announced an annual dividend on Wednesday, December 13th. Shareholders of record on Wednesday, December 27th will be paid a dividend of $0.42 per share on Friday, January 19th. This represents a yield of 0.5%. The ex-dividend date of this dividend is Tuesday, December 26th. This is a positive change from Balchem's previous annual dividend of $0.38. View Balchem's Dividend History.
How were Balchem's earnings last quarter?
Balchem Co. (NASDAQ:BCPC) announced its quarterly earnings results on Friday, May, 4th. The basic materials company reported $0.76 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.70 by $0.06. The basic materials company had revenue of $161.41 million for the quarter. Balchem had a net margin of 15.18% and a return on equity of 14.50%. View Balchem's Earnings History.
When is Balchem's next earnings date?
What price target have analysts set for BCPC?
2 equities research analysts have issued 1-year price targets for Balchem's shares. Their forecasts range from $85.00 to $85.00. On average, they anticipate Balchem's stock price to reach $85.00 in the next twelve months. View Analyst Ratings for Balchem.
Who are some of Balchem's key competitors?
Some companies that are related to Balchem include FMC (FMC), Johnson Matthey (JMPLY), The Chemours (CC), Huntsman (HUN), Olin (OLN), Ashland (ASH), W. R. Grace and (GRA), Univar (UNVR), Ingevity (NGVT), GCP Applied Technologies (GCP), PQ Group (PQG), Innospec (IOSP), KMG Chemicals (KMG), Innophos (IPHS) and OCI Partners (OCIP).
Who are Balchem's key executives?
Balchem's management team includes the folowing people:
- Mr. Theodore L. Harris, Chairman & Chief Exec. Officer (Age 53)
- Mr. William A. Backus CPA, Chief Accounting Officer & Treasurer (Age 52)
- Mr. David F. Ludwig, VP and GM of Specialty & Industrial Products (Age 60)
- Ms. Mary Theresa Coelho, Chief Financial Officer
- Mr. Michael Sestrick, Chief Technology Officer
Has Balchem been receiving favorable news coverage?
Media stories about BCPC stock have trended somewhat positive on Saturday, according to Accern. Accern rates the sentiment of press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Balchem earned a media sentiment score of 0.06 on Accern's scale. They also gave news stories about the basic materials company an impact score of 44.36 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
Who are Balchem's major shareholders?
Balchem's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (12.60%), Neuberger Berman Group LLC (4.80%), Wasatch Advisors Inc. (2.60%), Dimensional Fund Advisors LP (2.28%), Royal Bank of Canada (1.70%) and New York State Common Retirement Fund (1.59%). Company insiders that own Balchem stock include Dino A Rossi, Edward Mcmillan, Matthew David Houston and William A Backus. View Institutional Ownership Trends for Balchem.
Which major investors are selling Balchem stock?
BCPC stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Neuberger Berman Group LLC, Eagle Asset Management Inc., PNC Financial Services Group Inc., Cortina Asset Management LLC, New York State Common Retirement Fund, Sei Investments Co. and Royal Bank of Canada. View Insider Buying and Selling for Balchem.
Which major investors are buying Balchem stock?
BCPC stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Carillon Tower Advisers Inc., Schwab Charles Investment Management Inc., JPMorgan Chase & Co., MetLife Investment Advisors LLC, Russell Investments Group Ltd., Rhumbline Advisers and Van ECK Associates Corp. View Insider Buying and Selling for Balchem.
How do I buy shares of Balchem?
Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Balchem's stock price today?
One share of BCPC stock can currently be purchased for approximately $96.87.
How big of a company is Balchem?
Balchem has a market capitalization of $3.10 billion and generates $594.79 million in revenue each year. Balchem employs 1,165 workers across the globe.
How can I contact Balchem?
Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]
MarketBeat Community Rating for Balchem (BCPC)
MarketBeat's community ratings are surveys of what our community members think about Balchem and other stocks. Vote "Outperform" if you believe BCPC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BCPC will underperform the S&P 500 over the long term. You may vote once every thirty days.
Balchem (NASDAQ:BCPC) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for Balchem in the last 12 months. Their average twelve-month price target is $85.00, suggesting that the stock has a possible downside of 12.25%. The high price target for BCPC is $85.00 and the low price target for BCPC is $85.00. There are currently 2 hold ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | N/A | N/A | N/A |
| Consensus Rating Score: | 2.00 | N/A | N/A | N/A |
| Ratings Breakdown: | 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $85.00 | N/A | N/A | N/A |
| Price Target Upside: | 12.25% downside | N/A | N/A | N/A |
Balchem (NASDAQ:BCPC) Consensus Price Target History
Balchem (NASDAQ:BCPC) Analyst Ratings History
Show:
(Data available from 5/26/2016 forward)
Balchem (NASDAQ:BCPC) Earnings History and Estimates Chart
Balchem (NASDAQ BCPC) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/2/2018 | | $0.75 | | | | | N/A |  |
| 5/4/2018 | Q1 2018 | $0.70 | $0.76 | | $161.41 million | View | N/A | |
| 2/27/2018 | Q4 2017 | $0.62 | $0.68 | | $159.26 million | View | Listen | |
| 11/7/2017 | Q3 2017 | $0.62 | $0.63 | | $150.72 million | View | N/A | |
| 8/4/2017 | Q2 2017 | $0.63 | $0.64 | | $147.08 million | View | N/A | |
| 5/9/2017 | Q1 2017 | $0.6070 | $0.59 | | $137.73 million | View | N/A | |
| 2/28/2017 | Q4 2016 | $0.65 | $0.67 | | $140.76 million | View | N/A | |
| 11/4/2016 | Q3 2016 | $0.65 | $0.61 | | $138.51 million | View | N/A | |
| 8/5/2016 | Q2 | $0.65 | $0.66 | $134.77 million | $138.80 million | View | N/A | |
| 5/10/2016 | Q1 | $0.62 | $0.58 | $150.10 million | $135.10 million | View | N/A | |
| 2/29/2016 | Q4 | $0.57 | $0.66 | $144.70 million | $132.70 million | View | Listen | |
| 11/3/2015 | Q315 | $0.60 | $0.61 | $150.53 million | $140.10 million | View | N/A | |
| 8/4/2015 | Q215 | $0.56 | $0.62 | $148.87 million | $1.33 billion | View | N/A | |
| 5/5/2015 | Q115 | $0.59 | $0.62 | $147.90 million | $144.86 million | View | N/A | |
| 2/24/2015 | Q414 | $0.59 | $0.61 | $153.00 million | $162.60 million | View | N/A | |
| 11/10/2014 | Q314 | $0.51 | $0.49 | $157.00 million | $160.50 million | View | N/A | |
| 8/8/2014 | Q2 14 | $0.46 | $0.53 | | $132.23 million | View | N/A | |
| 5/5/2014 | Q1 2014 | | $0.32 | | $86.00 million | View | N/A | |
| 2/27/2014 | | $0.36 | $0.35 | | $81.63 million | View | N/A | |
| 11/5/2013 | Q212 | $0.41 | $0.38 | $86.75 million | $87.59 million | View | N/A | |
| 7/31/2013 | Q2 2013 | $0.39 | $0.38 | $88.30 million | $83.30 million | View | N/A | |
| 5/3/2013 | Q1 2013 | $0.37 | $0.36 | $83.32 million | $84.65 million | View | N/A | |
| 2/21/2013 | Q4 2012 | $0.34 | $0.33 | | | View | N/A | |
| 11/2/2012 | Q3 2012 | $0.35 | $0.36 | | | View | N/A | |
| 8/1/2012 | Q2 2012 | $0.31 | $0.33 | | | View | N/A | |
| 5/2/2012 | Q1 2012 | $0.32 | $0.31 | | | View | N/A | |
| 2/27/2012 | Q4 2011 | $0.35 | $0.31 | | | View | N/A | |
| 11/2/2011 | Q3 2011 | $0.33 | $0.36 | | | View | N/A | |
| 8/3/2011 | | $0.31 | $0.34 | | | View | N/A | |
| 5/3/2011 | Q1 2011 | $0.29 | $0.30 | | | View | N/A | |
| 2/28/2011 | Q4 2010 | $0.29 | $0.31 | | | View | N/A | |
| 10/29/2010 | Q3 2010 | $0.28 | $0.29 | | | View | N/A | |
| 8/3/2010 | Q2 2010 | $0.27 | $0.28 | | | View | N/A | |
| 5/4/2010 | Q1 2010 | $0.25 | $0.24 | | | View | N/A | |
| 2/25/2010 | Q4 2009 | $0.20 | $0.24 | | | View | N/A | |
| 10/29/2009 | Q3 2009 | $0.19 | $0.24 | | | View | N/A | |
| 7/30/2009 | Q2 2009 | | $0.24 | | | View | N/A | |
| 5/1/2009 | Q1 2009 | | $0.21 | | | View | N/A | |
| 2/24/2009 | Q4 2008 | $0.17 | $0.18 | | | View | N/A | |
| 10/30/2008 | Q3 2008 | $0.18 | $0.17 | | | View | N/A | |
| 7/31/2008 | Q2 2008 | $0.17 | $0.17 | | | View | N/A | |
| 5/8/2008 | Q1 2008 | $0.16 | $0.17 | | | View | N/A | |
| 3/4/2008 | Q4 2007 | $0.14 | $0.15 | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Balchem (NASDAQ:BCPC) Dividend Information
Balchem pays an annual dividend of $0.42 per share, with a dividend yield of 0.43%. BCPC's most recent annual dividend payment was Friday, January 19.
| Most Recent Dividend: | 1/19/2018 |
| Annual Dividend: | $0.42 |
| Dividend Yield: | 0.43% |
| Payout Ratio(s): | 10.62% (Based on Cash Flow)
N/A |
Balchem (NASDAQ:BCPC) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 12/13/2017 | Annual | $0.42 | 0.5% | 12/26/2017 | 12/27/2017 | 1/19/2018 |
| 12/15/2016 | Annual | $0.38 | 0.46% | 12/22/2016 | 12/27/2016 | 1/20/2017 |
| 12/18/2015 | annual | $0.34 | 0.55% | 12/23/2015 | 12/28/2015 | 1/21/2016 |
| 12/22/2014 | annual | $0.30 | 0.44% | 12/24/2014 | 12/29/2014 | 1/27/2015 |
| 12/16/2013 | annual | $0.26 | 0.45% | 12/19/2013 | 12/23/2013 | 1/21/2014 |
| 12/13/2013 | | $0.26 | | 12/19/2013 | 12/23/2013 | 1/21/2014 |
(Data available from 1/1/2013 forward)
Balchem (NASDAQ BCPC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.02%
Institutional Ownership Percentage: 87.38%
Balchem (NASDAQ BCPC) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 6/15/2017 | Edward Mcmillan | Director | Sell | 2,557 | $81.09 | $207,347.13 | 25,739 | |
| 3/13/2017 | William A Backus | CFO | Sell | 48,500 | $83.60 | $4,054,600.00 | 21,775 | |
| 3/3/2017 | William A Backus | CFO | Sell | 14,000 | $86.88 | $1,216,320.00 | 30,775 | |
| 1/4/2017 | Edward Mcmillan | Director | Sell | 1,550 | $85.00 | $131,750.00 | 27,008 | |
| 12/8/2016 | Dino A. Rossi | Director | Sell | 16,762 | $84.68 | $1,419,406.16 | | |
| 11/16/2016 | Dino A. Rossi | Director | Sell | 16,400 | $77.85 | $1,276,740.00 | | |
| 10/7/2016 | Dino A Rossi | Director | Sell | 16,400 | $78.57 | $1,288,548.00 | 23,248 | |
| 9/20/2016 | Matthew David Houston | General Counsel | Sell | 4,000 | $67.83 | $271,320.00 | 20,050 | |
| 9/9/2016 | Dino A Rossi | Director | Sell | 16,400 | $68.26 | $1,119,464.00 | 39,648 | |
| 9/2/2016 | Edward Mcmillan | Director | Sell | 1,500 | $69.75 | $104,625.00 | 28,558 | |
| 8/26/2016 | William A Backus | CFO | Sell | 12,000 | $68.64 | $823,680.00 | 29,308 | |
| 8/10/2016 | Dino A Rossi | Director | Sell | 16,400 | $65.31 | $1,071,084.00 | 56,048 | |
| 7/14/2016 | Dino A Rossi | Director | Sell | 16,600 | $62.31 | $1,034,346.00 | 72,448 | |
| 6/20/2016 | Edward Mcmillan | Director | Sell | 3,076 | $60.25 | $185,329.00 | 33,058 | |
| 6/17/2016 | Dino A Rossi | Director | Sell | 32,400 | $59.35 | $1,922,940.00 | 113,248 | |
| 5/19/2016 | Dino A Rossi | Director | Sell | 200 | $58.39 | $11,678.00 | 98,085 | |
| 5/16/2016 | Matthew David Houston | General Counsel | Sell | 5,000 | $62.51 | $312,550.00 | 28,550 | |
| 4/20/2016 | Dino A Rossi | Director | Sell | 16,400 | $63.15 | $1,035,660.00 | 137,085 | |
| 3/23/2016 | Dino A Rossi | Director | Sell | 16,400 | $59.68 | $978,752.00 | 137,085 | |
| 9/16/2015 | Dino A. Rossi | Chairman | Sell | 14,600 | $58.81 | $858,626.00 | 146,195 | |
| 8/14/2015 | Dino A Rossi | Chairman | Sell | 14,600 | $60.58 | $884,468.00 | | |
| 7/15/2015 | Dino A Rossi | Chairman | Sell | 7,300 | $55.58 | $405,734.00 | | |
| 7/14/2015 | Dino A Rossi | Chairman | Sell | 7,300 | $55.04 | $401,792.00 | | |
| 7/13/2015 | David F Ludwig | VP | Sell | 15,000 | $55.05 | $825,750.00 | | |
| 6/12/2015 | Frank Fitzpatrick | VP | Sell | 14,935 | $61.20 | $914,022.00 | | |
| 6/11/2015 | Dino A Rossi | CEO | Sell | 14,600 | $60.45 | $882,570.00 | | |
| 6/10/2015 | David F Ludwig | VP | Sell | 15,000 | $59.66 | $894,900.00 | | |
| 5/15/2015 | Frank Fitzpatrick | VP | Sell | 14,000 | $57.10 | $799,400.00 | | |
| 5/12/2015 | David F Ludwig | VP | Sell | 15,000 | $56.51 | $847,650.00 | | |
| 5/8/2015 | Dino A Rossi | Chairman | Sell | 14,600 | $57.72 | $842,712.00 | | |
| 5/7/2015 | David F Ludwig | VP | Sell | 28,500 | $58.14 | $1,656,990.00 | | |
| 4/16/2015 | David F Ludwig | VP | Sell | 1,500 | $58.26 | $87,390.00 | | |
| 4/15/2015 | Frank Fitzpatrick | VP | Sell | 14,000 | $55.43 | $776,020.00 | | |
| 4/7/2015 | Dino A Rossi | CEO | Sell | 14,600 | $55.90 | $816,140.00 | | |
| 3/16/2015 | Frank Fitzpatrick | VP | Sell | 14,000 | $56.07 | $784,980.00 | | |
| 3/4/2015 | Dino A Rossi | CEO | Sell | 14,600 | $58.11 | $848,406.00 | | |
| 2/18/2015 | David F Ludwig | VP | Sell | 15,000 | $58.16 | $872,400.00 | | |
| 2/17/2015 | Frank Fitzpatrick | VP | Sell | 14,000 | $57.85 | $809,900.00 | | |
| 2/5/2015 | Dino A Rossi | CEO | Sell | 14,600 | $54.34 | $793,364.00 | | |
| 1/15/2015 | Frank Fitzpatrick | VP | Sell | 14,000 | $60.59 | $848,260.00 | | |
| 1/12/2015 | David F Ludwig | VP | Sell | 15,000 | $61.43 | $921,450.00 | | |
| 1/8/2015 | Dino A Rossi | CEO | Sell | 24,200 | $61.19 | $1,480,798.00 | | |
| 12/15/2014 | Frank Fitzpatrick | VP | Sell | 14,000 | $63.01 | $882,140.00 | | |
| 12/10/2014 | David F Ludwig | VP | Sell | 15,000 | $63.34 | $950,100.00 | | |
| 12/4/2014 | Dino A Rossi | CEO | Sell | 24,400 | $64.92 | $1,584,048.00 | | |
| 11/21/2014 | Dino A Rossi | CEO | Sell | 24,400 | $63.97 | $1,560,868.00 | | |
| 11/17/2014 | Frank Fitzpatrick | VP | Sell | 14,000 | $64.62 | $904,680.00 | | |
| 10/7/2014 | Dino A Rossi | CEO | Sell | 24,400 | $54.56 | $1,331,264.00 | | |
| 9/15/2014 | Frank Fitzpatrick | VP | Sell | 14,000 | $54.82 | $767,480.00 | | |
| 9/12/2014 | Dino A Rossi | CEO | Sell | 36,400 | $54.95 | $2,000,180.00 | | |
| 8/12/2014 | Dino A Rossi | CEO | Sell | 19,800 | $53.25 | $1,054,350.00 | | |
| 7/15/2014 | Frank Fitzpatrick | VP | Sell | 14,000 | $49.68 | $695,520.00 | | |
| 7/9/2014 | Dino A Rossi | CEO | Sell | 17,000 | $53.48 | $909,160.00 | | |
| 7/8/2014 | Dino A Rossi | CEO | Sell | 12,200 | $53.42 | $651,724.00 | | |
| 6/20/2014 | Dino A Rossi | CEO | Sell | 24,400 | $53.38 | $1,302,472.00 | | |
| 6/16/2014 | Frank Fitzpatrick | CFO | Sell | 14,000 | $53.43 | $748,020.00 | | |
| 5/15/2014 | Frank Fitzpatrick | CFO | Sell | 14,000 | $52.44 | $734,160.00 | | |
| 4/15/2014 | Frank Fitzpatrick | CFO | Sell | 21,003 | $62.00 | $1,302,186.00 | | |
| 3/17/2014 | Frank Fitzpatrick | CFO | Sell | 14,000 | $55.24 | $773,360.00 | | |
| 2/21/2014 | Dino A Rossi | CEO | Sell | 15,000 | $50.10 | $751,500.00 | | |
| 2/18/2014 | Frank Fitzpatrick | CFO | Sell | 14,000 | $51.48 | $720,720.00 | | |
| 2/10/2014 | David F Ludwig | VP | Sell | 13,500 | $50.74 | $684,990.00 | | |
| 1/23/2014 | Dino A Rossi | CEO | Sell | 15,000 | $56.82 | $852,300.00 | | |
| 1/15/2014 | Frank Fitzpatrick | CFO | Buy | 14,000 | $11.87 | $166,180.00 | | |
| 1/10/2014 | David F Ludwig | VP | Sell | 13,500 | $56.05 | $756,675.00 | | |
| 12/24/2013 | Dino A Rossi | CEO | Sell | 15,000 | $57.80 | $867,000.00 | | |
| 12/18/2013 | Elaine R Wedral | Director | Sell | 8,243 | $57.13 | $470,922.59 | | |
| 12/16/2013 | Edward Mcmillan | Director | Sell | 8,000 | $58.40 | $467,200.00 | | |
| 12/13/2013 | John Y Televantos | Director | Sell | 2,000 | $57.23 | $114,460.00 | | |
| 12/10/2013 | David F Ludwig | VP | Sell | 13,500 | $57.39 | $774,765.00 | | |
| 12/2/2013 | Frank Fitzpatrick | CFO | Sell | 13,500 | $57.38 | $774,630.00 | | |
| 10/18/2013 | Dino A Rossi | CEO | Sell | 15,000 | $57.38 | $860,700.00 | | |
| 10/10/2013 | David F Ludwig | VP | Sell | 13,500 | $52.76 | $712,260.00 | | |
| 9/20/2013 | Dino A Rossi | CEO | Sell | 15,000 | $50.43 | $756,450.00 | | |
| 9/19/2013 | John Y Televantos | Director | Sell | 4,000 | $49.60 | $198,400.00 | | |
| 9/18/2013 | Edward Mcmillan | Director | Sell | 33,488 | $49.79 | $1,667,367.52 | | |
| 9/10/2013 | David F Ludwig | VP | Sell | 13,500 | $49.38 | $666,630.00 | | |
| 9/4/2013 | Frank Fitzpatrick | CFO | Sell | 13,500 | $47.77 | $644,895.00 | | |
| 8/20/2013 | Dino A Rossi | CEO | Sell | 15,000 | $50.18 | $752,700.00 | | |
| 8/8/2013 | David F Ludwig | VP | Sell | 24,538 | $52.54 | $1,289,226.52 | | |
| 8/7/2013 | John Y Televantos | Director | Sell | 5,000 | $52.79 | $263,950.00 | | |
| 8/1/2013 | Frank Fitzpatrick | CFO | Sell | 22,198 | $34.28 | $760,947.44 | | |
| 7/19/2013 | Dino A Rossi | CEO | Sell | 15,000 | $47.04 | $705,600.00 | | |
| 7/1/2013 | Frank Fitzpatrick | CFO | Sell | 13,500 | $45.21 | $610,335.00 | | |
| 6/20/2013 | Dino A Rossi | CEO | Sell | 15,000 | $45.49 | $682,350.00 | | |
| 6/18/2013 | Elaine R Wedral | Director | Sell | 4,488 | $46.00 | $206,448.00 | | |
| 6/13/2013 | Elaine R Wedral | Director | Sell | 4,000 | $45.96 | $183,840.00 | | |
| 6/6/2013 | Dana E Putnam | Insider | Sell | 36,645 | $47.25 | $1,731,476.25 | | |
| 6/3/2013 | Frank Fitzpatrick | CFO | Sell | 13,500 | $47.90 | $646,650.00 | | |
| 5/10/2013 | Matthew David Houston | General Counsel | Sell | 41,229 | $43.16 | $1,779,443.64 | | |
| 11/8/2012 | Paul D Coombs | Director | Buy | 6,000 | $32.41 | $194,460.00 | | |
(Data available from 1/1/2013 forward)
Balchem (NASDAQ BCPC) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Hawkins (HWKN) versus Balchem (BCPC) Head-To-Head Contrast
www.americanbankingnews.com - May 25 at 3:18 AM |
 | Balchem (BCPC) Presents At Houlihan Lokey's 13th Annual Global Industrial Conference - Slideshow
seekingalpha.com - May 18 at 4:40 PM |
| Critical Analysis: Ingevity (NGVT) & Balchem (BCPC)
www.americanbankingnews.com - May 17 at 12:01 PM |
| Balchem (BCPC) Downgraded by BidaskClub to "Buy"
www.americanbankingnews.com - May 12 at 4:24 PM |
 | Balchem Reports Strong Growth to Begin 2018
www.fool.com - May 9 at 2:52 PM |
| Critical Review: Olin (OLN) & Balchem (BCPC)
www.americanbankingnews.com - May 9 at 5:23 AM |
| Vertical Group Reiterates "Hold" Rating for Balchem (BCPC)
www.americanbankingnews.com - May 7 at 2:58 PM |
| Balchem (BCPC) Lifted to Hold at Pivotal Research
www.americanbankingnews.com - May 7 at 12:45 PM |
 | Pivotal Research Upgrades Balchem (BCPC) to Hold, Says Shares are Richly Priced
www.streetinsider.com - May 7 at 9:12 AM |
| Balchem Corporation (BCPC) CEO Theodore Harris on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 5 at 9:39 AM |
 | Edited Transcript of BCPC earnings conference call or presentation 4-May-18 3:00pm GMT
finance.yahoo.com - May 5 at 9:39 AM |
| Balchem (BCPC) Issues Quarterly Earnings Results, Beats Expectations By $0.08 EPS
www.americanbankingnews.com - May 4 at 4:37 PM |
 | BRIEF-Balchem Corp Q1 Adjusted EPS $0.76
www.reuters.com - May 4 at 9:18 AM |
| Balchem beats by $0.05, beats on revenue
seekingalpha.com - May 4 at 9:18 AM |
| Blachem: 1Q Earnings Snapshot
finance.yahoo.com - May 4 at 9:18 AM |
| Balchem Corporation Reports Record First Quarter Sales of $161.4 Million, Record First Quarter Net Earnings of $19.3 Million, Record Adjusted Net Earnings of $24.4 Million and Record Adjusted EBITDA of $40.9 Million
finance.yahoo.com - May 4 at 9:18 AM |
| BASF (BASFY) versus Balchem (BCPC) Head-To-Head Contrast
www.americanbankingnews.com - May 3 at 1:35 AM |
| Analyzing Balchem (BCPC) and Ashland (ASH)
www.americanbankingnews.com - April 27 at 7:22 PM |
| Balchem (BCPC) to Release Quarterly Earnings on Friday
www.americanbankingnews.com - April 27 at 1:16 AM |
 | Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May
www.nasdaq.com - April 24 at 9:20 AM |
 | Balchem Corporation Announces Quarterly Conference Call for First Quarter ...
globenewswire.com - April 23 at 4:29 PM |
| Balchem (BCPC) Lowered to "Strong Sell" at BidaskClub
www.americanbankingnews.com - April 15 at 12:36 AM |
| Balchem (BCPC) Upgraded by BidaskClub to "Strong-Buy"
www.americanbankingnews.com - April 11 at 11:30 AM |
| Edited Transcript of BCPC earnings conference call or presentation 27-Feb-18 4:00pm GMT
finance.yahoo.com - March 28 at 9:37 AM |
| Balchem (BCPC) Rating Increased to Buy at BidaskClub
www.americanbankingnews.com - March 27 at 5:10 PM |
| Balchem (BCPC) Upgraded by BidaskClub to "Hold"
www.americanbankingnews.com - March 17 at 7:16 PM |
| Health and Nutrition Growth Drives Balchem Corporation
finance.yahoo.com - March 6 at 9:15 AM |
| 540,300 Shares in Balchem Co. (BCPC) Purchased by Santa Monica Partners LP
www.americanbankingnews.com - March 6 at 9:11 AM |
| Citadel Advisors LLC Has $1.01 Million Position in Balchem Co. (BCPC)
www.americanbankingnews.com - March 5 at 5:42 AM |
| Balchem (BCPC) Lifted to "Sell" at BidaskClub
www.americanbankingnews.com - March 3 at 6:10 PM |
| State of Tennessee Treasury Department Sells 2,740 Shares of Balchem Co. (BCPC)
www.americanbankingnews.com - March 3 at 10:12 AM |
| Balchem Co. (BCPC) Holdings Raised by Swiss National Bank
www.americanbankingnews.com - March 3 at 7:34 AM |
| Eaton Vance Management Has $11.60 Million Holdings in Balchem Co. (BCPC)
www.americanbankingnews.com - February 28 at 11:12 AM |
| Balchem Co. (BCPC) Holdings Increased by Raymond James Financial Services Advisors Inc.
www.americanbankingnews.com - February 28 at 6:50 AM |
| Schwab Charles Investment Management Inc. Purchases 16,782 Shares of Balchem Co. (BCPC)
www.americanbankingnews.com - February 28 at 5:44 AM |
| Balchem (BCPC) Releases Quarterly Earnings Results, Beats Expectations By $0.06 EPS
www.americanbankingnews.com - February 27 at 5:32 PM |
| Balchem Co. (BCPC) Position Decreased by Cortina Asset Management LLC
www.americanbankingnews.com - February 27 at 1:40 PM |
| Martingale Asset Management L P Sells 8,903 Shares of Balchem Co. (BCPC)
www.americanbankingnews.com - February 27 at 12:58 PM |
| Balchem Corporation Reports Fourth Quarter Sales of $159.3 Million with Record Net Earnings of $42.0 Million, Record Adjusted Net Earnings of $21.9 Million and Record Adjusted EBITDA of $40.0 Million
finance.yahoo.com - February 27 at 9:24 AM |
| Balchem Corporation to Host Earnings Call
finance.yahoo.com - February 27 at 9:24 AM |
| Arizona State Retirement System Has $4.34 Million Position in Balchem Co. (BCPC)
www.americanbankingnews.com - February 27 at 4:24 AM |
| Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 27, 2018
finance.yahoo.com - February 20 at 4:57 PM |
| Balchem (BCPC) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - February 19 at 4:10 AM |
| Local researcher awarded $2.6M grant to create test for important, little-known nutrient
finance.yahoo.com - February 16 at 4:39 PM |
| Balchem Co. (BCPC) Short Interest Down 26.0% in January
www.americanbankingnews.com - January 29 at 1:20 AM |
| Factors of Influence in 2018, Key Indicators and Opportunity within Kelly Services, Genocea Biosciences, Balchem, Federal Signal, Marriott Vacations Worldwide, and International Bancshares — New Research Emphasizes Economic Growth
finance.yahoo.com - January 8 at 9:04 AM |
| ETFs with exposure to Balchem Corp. : December 29, 2017
finance.yahoo.com - December 29 at 3:53 PM |
| Balchem Corp. : BCPC-US: Dividend Analysis : December 27th, 2017 (record date) : By the numbers : December 27, 2017
finance.yahoo.com - December 27 at 11:58 AM |
| Cash Dividend On The Way From Balchem (BCPC)
www.nasdaq.com - December 23 at 4:49 PM |
| Balchem (BCPC) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - December 22 at 10:01 PM |
Balchem (NASDAQ:BCPC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Balchem (NASDAQ:BCPC) Income Statement, Balance Sheet and Cash Flow Statement
Balchem (NASDAQ BCPC) Stock Chart for Saturday, May, 26, 2018
Loading chart…
